PAM - peptidylglycine alpha-amidating monooxygenase Gene
Species: Felis catus
Gene Type: protein coding
Gene ID: 101084598
PAM Products (16)
| mRNA | Protein | Name |
|---|---|---|
| XM_023258791.2 | XP_023114559.1 | peptidyl-glycine alpha-amidating monooxygenase isoform X1 |
| XM_045034321.1 | XP_044890256.1 | peptidyl-glycine alpha-amidating monooxygenase isoform X1 |
| XM_023258812.2 | XP_023114580.1 | peptidyl-glycine alpha-amidating monooxygenase isoform X4 |
| XM_023258813.2 | XP_023114581.1 | peptidyl-glycine alpha-amidating monooxygenase isoform X5 |
| XM_023258817.2 | XP_023114585.1 | peptidyl-glycine alpha-amidating monooxygenase isoform X8 |
| XM_023258826.2 | XP_023114594.1 | peptidyl-glycine alpha-amidating monooxygenase isoform X11 |
| XM_023258827.2 | XP_023114595.1 | peptidyl-glycine alpha-amidating monooxygenase isoform X12 |
| XM_023258797.2 | XP_023114565.1 | peptidyl-glycine alpha-amidating monooxygenase isoform X2 |
| XM_023258807.2 | XP_023114575.1 | peptidyl-glycine alpha-amidating monooxygenase isoform X3 |
| XM_023258814.2 | XP_023114582.1 | peptidyl-glycine alpha-amidating monooxygenase isoform X6 |
| XM_023258815.2 | XP_023114583.1 | peptidyl-glycine alpha-amidating monooxygenase isoform X7 |
| XM_023258823.2 | XP_023114591.1 | peptidyl-glycine alpha-amidating monooxygenase isoform X9 |
| XM_023258824.2 | XP_023114592.1 | peptidyl-glycine alpha-amidating monooxygenase isoform X10 |
| XM_023258830.2 | XP_023114598.1 | peptidyl-glycine alpha-amidating monooxygenase isoform X13 |
| XM_045034393.1 | XP_044890328.1 | peptidyl-glycine alpha-amidating monooxygenase isoform X14 |
| XM_023258836.2 | XP_023114604.1 | peptidyl-glycine alpha-amidating monooxygenase isoform X15 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
peptidyl-glycine alpha-amidating monooxygenase |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(6)
| Cat. No. | 상품명 |
효과
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-A0106 | Levamisole | 99.97% | Yes | |
| HY-B0288B | Fenoprofen Calcium hydrate | 99.52% | Unkown | |
| HY-B1200 | Pralidoxime chloride | Activator | 99.98% | Unkown |
| HY-B1456A | Fenoprofen | 99.70% | Unkown | |
| HY-B0288A | Fenoprofen Calcium | / | Unkown | |
| HY-B0288BR | Fenoprofen Calcium hydrate (Standard) | / | Unkown |
Clinical Phase
Bioactive Molecules
(5)
| Cat. No. | 상품명 |
효과
|
Purity |
Phase |
|---|---|---|---|---|
| HY-111052 | AZD7325 | 99.95% | Phase 2 | |
| HY-128770 | LY3154207 | Agonist | 98.06% | Phase 2 |
| HY-132806 | Alogabat | Agonist | 99.93% | Phase 2 |
| HY-108703 | Foliglurax | Agonist | / | Phase 2 |
| HY-144291 | LY3154885 | Agonist | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(181)
| Cat. No. | 상품명 |
효과
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P1180A | Pam3CSK4 TFA | Agonist | 99.89% | Unkown |
| HY-108471 | CU-CPT22 | Inhibitor | ≥99.0% | Unkown |
| HY-112146 | MMG-11 | Antagonist | 99.24% | Unkown |
| HY-115467 | MitoBloCK-10 | 98.99% | Unkown | |
| HY-110279 | Ogerin | Modulator | 99.94% | Unkown |
| HY-113320 | Etiocholanolone | Modulator | 99.49% | Unkown |
| HY-P1181A | Pam2CSK4 TFA | 99.46% | Unkown | |
| HY-120874 | Darigabat | Activator | 99.29% | Unkown |
| HY-13058 | ADX-47273 | Agonist | 99.34% | Unkown |
| HY-W015464 | N-Isovaleroylglycine | 99.86% | Unkown | |
| HY-108703A | Foliglurax monohydrochloride | Agonist | 98.57% | Yes |
| HY-120023 | VU0453595 | Agonist | 99.90% | Unkown |
| HY-18654 | ADX88178 | Agonist | 99.50% | Unkown |
| HY-N0754 | Eupalinolide A | 99.92% | Unkown | |
| HY-I0673 | Flucofuron | Inducer | 99.75% | Unkown |
| HY-100605 | VU0483605 | Modulator | 97.30% | Unkown |
| HY-116819 | VU0453379 | Modulator | 98.0% | Unkown |
| HY-129086 | BPAM344 | Agonist | 99.66% | Unkown |
| HY-W115727B | Polyacrylamide,Anion,Mw 18 million | ≥98.0% | Unkown | |
| HY-103475 | GS39783 | Agonist | 99.80% | Unkown |
| HY-113346 | Tetrahydrodeoxycorticosterone | Agonist | 99.45% | Unkown |
| HY-173396 | VU0467319 | Modulator | 98.53% | Unkown |
| HY-120613 | BMS-986187 | Activator | 99.66% | Unkown |
| HY-169329 | BIO-2007817 | Modulator | 99.35% | Unkown |
| HY-W115727A | Polyacrylamide,Anion,Mw 14-16 million | / | Unkown | |
| HY-112146A | MMG-11 quarterhydrate | Antagonist | 98.74% | Unkown |
| HY-122255 | LY487379 | Inhibitor | 98.92% | Unkown |
| HY-122819 | Calindol hydrochloride | Agonist | 99.64% | Unkown |
| HY-14612 | CPPHA | Modulator | 98.06% | Unkown |
| HY-114933 | VU0119498 | Modulator | 98.76% | Unkown |
| HY-120530 | JNJ-46281222 | Inhibitor | 98.77% | Unkown |
| HY-12158 | VU0238441 | Activator | 99.87% | Unkown |
| HY-12439 | ML380 | Agonist | 99.87% | Unkown |
| HY-149453 | MCUF-651 | Modulator | 99.85% | Unkown |
| HY-100588 | VU0364770 | Agonist | 99.94% | Unkown |
| HY-121806 | VU0486846 | Modulator | 99.5% | Unkown |
| HY-124372 | JNJ-46356479 | Modulator | 99.77% | Unkown |
| HY-124821 | VA012 | Modulator | 99.34% | Unkown |
| HY-126327A | UNC4976 TFA | Antagonist | 95.59% | Unkown |
| HY-131004 | CB2R PAM | Agonist | 98.09% | Unkown |
| HY-136190 | TRPC6-PAM-C20 | Agonist | 99.78% | Unkown |
| HY-143312E | (S)-V-0219 hydrochloride | Modulator | 99.71% | Unkown |
| HY-14417 | VU0155041 | Agonist | 99.10% | Unkown |
| HY-156331 | VU6004909 | Activator | 99.40% | Unkown |
| HY-113346S | Tetrahydrodeoxycorticosterone-d3 | Agonist | 99.53% | Unkown |
| HY-W141789 | Pam3-Cys-OH | 99.91% | Unkown | |
| HY-101841 | LY 2033298 | Activator | 99.87% | Unkown |
| HY-108340 | PF-06767832 | Agonist | 98.37% | Unkown |
| HY-116463 | E1R | Agonist | 99.83% | Unkown |
| HY-117851 | AC-265347 | Agonist | 99.97% | Unkown |
| HY-124419 | RO0711401 | Agonist | 98.42% | Unkown |
| HY-141515 | BMS-986121 | Modulator | 99.96% | Unkown |
| HY-143312D | (R)-V-0219 hydrochloride | Modulator | 98.92% | Unkown |
| HY-148867 | UCM-1306 | Modulator | 99.49% | Unkown |
| HY-165613 | Pam2Cys | 99.82% | Unkown | |
| HY-107423 | GNE 6901 | Agonist | 99.31% | Unkown |
| HY-114978 | VU0424465 | Agonist | 99.84% | Unkown |
| HY-117408 | VU6004256 | Modulator | 99.61% | Unkown |
| HY-118179 | VU0486321 | Agonist | 99.30% | Unkown |
| HY-119226 | VU0152099 | Agonist | 98.39% | Unkown |
| HY-120184 | VU0467485 | Agonist | 99.29% | Unkown |
| HY-126327 | UNC4976 | Antagonist | / | Unkown |
| HY-139044 | VU6000918 | Activator | 99.92% | Unkown |
| HY-14418 | VU0361737 | Agonist | 99.65% | Unkown |
| HY-14419 | TCN238 | Modulator | 99.57% | Unkown |
| HY-162454 | DA-023 | Modulator | 98.01% | Unkown |
| HY-RS10011 | PAM Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-11048 | NS11394 | Modulator | 99.77% | Unkown |
| HY-W115727E | Polyacrylamide,average Mn 150000 | / | Unkown | |
| HY-W338852 | Gentisuric acid | 99.65% | Unkown | |
| HY-103571 | VU0285683 | Antagonist | 99.76% | Unkown |
| HY-107504 | VU0360172 hydrochloride | Agonist | 98.94% | Unkown |
| HY-113689 | GAT211 | Agonist | 99.96% | Unkown |
| HY-114863 | PHCCC(4Me) | Modulator | 99.99% | Unkown |
| HY-116819A | VU0453379 hydrochloride | Modulator | 99.0% | Unkown |
| HY-116855 | TASP0433864 | Modulator | 99.9% | Unkown |
| HY-118416 | BMS-986124 | Antagonist | 99.00% | Unkown |
| HY-119078 | VU0080241 | Modulator | 99.69% | Unkown |
| HY-137204 | COR659 | Activator | 99.94% | Unkown |
| HY-16951 | VU-1545 | Agonist | 99.00% | Unkown |
| HY-175504 | MLS6357 | Antagonist | 99.57% | Unkown |
| HY-P1180 | Pam3CSK4 | Agonist | / | Unkown |
| HY-P1405A | Pam3CSK4-Biotin TFA | Agonist | 98.02% | Unkown |
| HY-P5352 | Hyaluronan-IN-1 | Inhibitor | 99.84% | Unkown |
| HY-113320S | Etiocholanolone-d5 | Modulator | 99.20% | Unkown |
| HY-12149 | A-867744 | Agonist | 99.76% | Unkown |
| HY-121600 | GAT229 | Modulator | 99.8% | Unkown |
| HY-15393 | VU 0357121 | Agonist | 99.73% | Unkown |
| HY-112814 | VU6001376 | / | Unkown | |
| HY-128584 | VU6005806 | Agonist | / | Unkown |
| HY-103497 | U-89843A hydrochloride | Activator | / | Unkown |
| HY-103552 | LY487379 hydrochloride | Modulator | / | Unkown |
| HY-107506 | Ro 67-4853 | Agonist | 99.90% | Unkown |
| HY-113320S1 | Etiocholanolone-d2 | Modulator | / | Unkown |
| HY-113608 | VCP171 | Modulator | 99.18% | Unkown |
| HY-116149 | A-424274 | Agonist | / | Unkown |
| HY-116463A | (2R,3S)-E1R | Agonist | 98.84% | Unkown |
| HY-116463B | (2S,3S)-E1R | Agonist | 98.24% | Unkown |
| HY-116463C | (2R,3R)-E1R | Agonist | 98.79% | Unkown |
| HY-116463D | (Rac)-E1R | Agonist | 98.48% | Unkown |
| HY-118022 | VU0361747 | / | Unkown | |
| HY-118256 | LSN2814617 | Modulator | / | Unkown |
| HY-119363 | VU6009453 | Agonist | / | Unkown |
| HY-120004 | PF-06827443 | / | Unkown | |
| HY-120576 | ML169 | Modulator | / | Unkown |
| HY-120727 | VU0364289 | Activator | 99.52% | Unkown |
| HY-124112 | PAM 1392 | Inhibitor | / | Unkown |
| HY-128783 | VU0090157 | Modulator | / | Unkown |
| HY-129431 | U-89843A | Activator | 99.26% | Unkown |
| HY-131196 | M3 mAChR agonist 1 | Agonist | / | Unkown |
| HY-134912 | CMPPE | Modulator | / | Unkown |
| HY-136258 | nAChR agonist CMPI hydrochloride | Agonist | / | Unkown |
| HY-136327 | Phenylacetic acid mustard | Inhibitor | / | Unkown |
| HY-143312B | (R)-V-0219 | Modulator | / | Unkown |
| HY-143312C | (S)-V-0219 | Modulator | / | Unkown |
| HY-14417B | VU0155041 sodium | Agonist | / | Unkown |
| HY-147421 | Xilmenolone | Modulator | / | Unkown |
| HY-149975 | AMPA receptor modulator-4 | Activator | / | Unkown |
| HY-151899 | A3AR modulator 1 | Agonist | / | Unkown |
| HY-155628 | AMPA receptor modulator-6 | Modulator | / | Unkown |
| HY-159177 | M4 mAChR Modulator-1 | Modulator | / | Unkown |
| HY-159624 | KK-92A | Modulator | / | Unkown |
| HY-160529 | α7 nAChR Modulator-2 | Modulator | / | Unkown |
| HY-161810 | MRS8247 | Modulator | / | Unkown |
| HY-162662 | VU6008677 | / | Unkown | |
| HY-163280 | JGB-1-155 | Activator | / | Unkown |
| HY-167922S | Heptadecanoyl L-carnitine-d3 HCl | / | Unkown | |
| HY-168025 | VU6007496 | Modulator | / | Unkown |
| HY-169247 | Pam2CS-DMAPA | / | Unkown | |
| HY-170499 | VU6024578 | Agonist | / | Unkown |
| HY-170903 | GABAA receptor modulator-3 | Agonist | / | Unkown |
| HY-171981 | VU6002703 | Modulator | / | Unkown |
| HY-172981 | CTW0404 | Modulator | / | Unkown |
| HY-172982 | CTW0419 | Modulator | / | Unkown |
| HY-173032 | VU6033685 | Agonist | / | Unkown |
| HY-173251S | ENX-101 | Modulator | / | Unkown |
| HY-175505 | Dopamine D3 receptor antagonist-3 | Antagonist | / | Unkown |
| HY-175508 | NMDA receptor modulator 9 | Agonist | / | Unkown |
| HY-175532 | M4 mAChR Modulator-2 | Activator | / | Unkown |
| HY-175670 | GABAA receptor modulator-10 | Agonist | / | Unkown |
| HY-178153 | BPAM363 | Modulator | / | Unkown |
| HY-178783 | MRS8454 | Modulator | / | Unkown |
| HY-179240 | UNC9815 | Modulator | / | Unkown |
| HY-179621 | EQ-04 | / | Unkown | |
| HY-180400 | PAM-2 | / | Unkown | |
| HY-181956 | MPAM-15 | Modulator | / | Unkown |
| HY-182450 | WX-293 | Inhibitor | / | Unkown |
| HY-185007 | LI-633 | Agonist | / | Unkown |
| HY-18679 | TC-N 22A | Agonist | / | Unkown |
| HY-19623 | VU0092273 | Agonist | 99.51% | Unkown |
| HY-B1456AS | Fenoprofen-13C6 sodium hydrate | / | Unkown | |
| HY-P1180B | Pam3CSK4 trihydrochloride | / | Unkown | |
| HY-P1181 | Pam2CSK4 | / | Unkown | |
| HY-P1405 | Pam3CSK4-Biotin | Agonist | / | Unkown |
| HY-P4802 | Pam3-Cys-Ala-Gly | Inhibitor | / | Unkown |
| HY-RS08881 | MYCBP2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS10012 | PAM16 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W015464R | N-Isovaleroylglycine (Standard) | / | Unkown | |
| HY-W015464S | N-Isovalerylglycine-d9 | 99.0% | Unkown | |
| HY-W015464S1 | N-Isovaleroylglycine-d2 | / | Unkown | |
| HY-W777503 | Calindol hydrochloride-13C,D2 | / | Unkown | |
| HY-103535 | GBLD345 | Agonist | / | Unkown |
| HY-111332 | (E)-PHCCC | Modulator | / | Unkown |
| HY-117611 | GAT107 | Modulator | / | Unkown |
| HY-119772 | VU0366369 | Modulator | / | Unkown |
| HY-122164 | LY-503430 | Agonist | / | Unkown |
| HY-123667 | NCFP | Modulator | / | Unkown |
| HY-123934 | VU6007477 | Modulator | / | Unkown |
| HY-129517 | UBP714 | Agonist | / | Unkown |
| HY-155467 | MRS7935 | Modulator | / | Unkown |
| HY-161113 | Z8554052021 | Activator | / | Unkown |
| HY-161118 | MB327 | / | Unkown | |
| HY-167922 | (R,R,S)-GAT107 | / | Unkown | |
| HY-173356 | Antiparasitic agent-26 | Inhibitor | / | Unkown |
| HY-RS16569 | Pam Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS19468 | Pam16 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS21160 | Mycbp2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23002 | Pam Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS25961 | Pam16 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS27676 | Mycbp2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W115727D | Polyacrylamide,average Mn 40000 | / | Unkown |
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Homo sapiens | PAM | NCBI | NCBI:5066 |
| Mus musculus | PAM | NCBI | NCBI:18484 |
| Rattus norvegicus | PAM | NCBI | NCBI:25508 |